We have an expansive network of pathology laboratories, diagnostic imaging centres and day hospitals. Through this footprint and through its 10,500 people, Healius provides specialty diagnostic services to consumers and their referring practitioners, as well as supporting independent healthcare professionals in the delivery of care in its centres and day hospitals. Healius provides quality healthcare services that are easily accessible and cost efficient, while supporting the coordination and continuity of quality patient care.
Overview
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 26, 2024 | C2N Receives $7.025M Funding | C2N, a St. Louis, MO-based diagnostics company developing Precivity blood tests, raised $7.025M in funding. The round was led by Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator. The company intends to use the funds to... |
| Sep 24, 2024 | Австралийская Healius продает подразделение визуализации Lumus компании Affinity за $657 млн | По данным компании Healius из Сиднея, в понедельник она заявила, что продажа Lumus компании Affinity Equity Partners в 25,4 раза превышает годовую прибыль до вычета процентов и налогов и принесет более 800 млн австралийских долларов чистой ... |
| Sep 23, 2024 | Australia's Healius to sell diagnostic imaging arm to Affinity for $657m | Australia’s Healius said on Monday it would sell its diagnostic imaging arm Lumus Imaging to private equity firm Affinity Equity Partners for an enterprise value of A$965 million ($657 million). |
| Nov 3, 2022 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 3rd November 2022 | This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and hu... |
| Mar 2, 2021 | Healius : Appendix 3Y Change of Director's Interest Notice - HLS | Appendix 3Y Change of Director's Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX beco... |
| Dec 24, 2020 | Healius : Appendix 3Y Change of Director's Interest Notice - | Appendix 3Y Change of Director's Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX beco... |
Reviews 0
FAQ about Healius Limited
When was Healius Limited founded?
Healius Limited was founded in 1986.
What has the press written about Healius Limited?
Parsers VC has collected 7 articles mentioning Healius Limited, among them “C2N Receives $7.025M Funding” (Sep 26, 2024) and “Австралийская Healius продает подразделение визуализации Lumus компании Affinity за $657 млн” (Sep 24, 2024).
Is Healius Limited still active?
Yes, Healius Limited is active; its latest activity on Parsers VC dates from Mar 24, 2025.